75 related articles for article (PubMed ID: 10081129)
1. [Neuroprotective effects of glycine in the acute period of ischemic stroke].
Gusev EI; Skvortsova VI; Komissarova IA; Dambinova SA; Raevskiĭ KS; Alekseev AA; Bashkatova VG; Kovalenko AV; Kudrin VS; Iakovleva EV
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(2):12-20. PubMed ID: 10081129
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of glycine for therapy of acute ischaemic stroke.
Gusev EI; Skvortsova VI; Dambinova SA; Raevskiy KS; Alekseev AA; Bashkatova VG; Kovalenko AV; Kudrin VS; Yakovleva EV
Cerebrovasc Dis; 2000; 10(1):49-60. PubMed ID: 10629347
[TBL] [Abstract][Full Text] [Related]
3. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
[TBL] [Abstract][Full Text] [Related]
5. [A comprehensive clinico-neurophysiological study of the efficacy of the pharmaceutical preparation glycine in acute ischemic stroke].
Skvortsova VI; Gusev EI; Komissarova IA; Kovalenko AV; Bolotov DA; Fidler SM; Fedorov VN
Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(1):11-9. PubMed ID: 7778387
[TBL] [Abstract][Full Text] [Related]
6. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
[TBL] [Abstract][Full Text] [Related]
7. [Levels of neurotransmitter amino acids in the cerebrospinal fluid of patients with acute ischemic stroke].
Skvortsova VI; Raevskiĭ KS; Kovalenko AV; Kudrin VS; Malikova LA; Sokolov MA; Alekseev AA; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(2):34-8. PubMed ID: 10081133
[TBL] [Abstract][Full Text] [Related]
8. [The level of autoantibodies to glutamate receptors in the blood serum of patients in the acute period of ischemic stroke].
Gusev EI; Skvortsova VI; Izykenova GA; Alekseev AA; Dambinova SA
Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(5):68-72. PubMed ID: 9012259
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia--CASTA.
Hong Z; Moessler H; Bornstein N; Brainin M; Heiss WD;
Int J Stroke; 2009 Oct; 4(5):406-12. PubMed ID: 19765131
[TBL] [Abstract][Full Text] [Related]
10. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
11. Application of glycine in acute alcohol hallucinosis.
Aliyev NA; Aliyev ZN
Hum Psychopharmacol; 2005 Dec; 20(8):591-4. PubMed ID: 16247737
[TBL] [Abstract][Full Text] [Related]
12. Role of glycine receptors and glycine release for the neuroprotective activity of bilobalide.
Kiewert C; Kumar V; Hildmann O; Hartmann J; Hillert M; Klein J
Brain Res; 2008 Mar; 1201():143-50. PubMed ID: 18325484
[TBL] [Abstract][Full Text] [Related]
13. [Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment].
Fridman EA; Ottaviano F; Fiol M; Javelier A; Perea JE; Ameriso SF
Rev Neurol; 2001 May 1-15; 32(9):818-21. PubMed ID: 11424030
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
[TBL] [Abstract][Full Text] [Related]
15. [Experimental evaluation of the effect of glycine and its phosphorylated derivative on ischemic brain injury].
Makarova LM; Pogorelyĭ VE
Eksp Klin Farmakol; 2006; 69(6):24-6. PubMed ID: 17209459
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?
Gorelick PB
Lancet; 2000 Jun; 355(9219):1925-6. PubMed ID: 10859032
[No Abstract] [Full Text] [Related]
17. The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA1021 on ischemic brain damage caused by acute subdural hematoma in the rat.
Tsuchida E; Bullock R
J Neurotrauma; 1995 Jun; 12(3):279-88. PubMed ID: 7473802
[TBL] [Abstract][Full Text] [Related]
18. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
19. [The objective of acute stroke therapy and neuroprotective therapeutic approaches].
Fisher M
Rev Neurol; 1999 Sep 16-30; 29(6):536-44. PubMed ID: 10584269
[TBL] [Abstract][Full Text] [Related]
20. [Autoantibodies to NMDA-type glutamate receptors in the blood of patients with acute ischemic and hemorrhagic stroke].
Skoromets AA; Dambinova SA; Iliukhina AIu; Sorokoumov VA
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):53-8. PubMed ID: 11517478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
